These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 31802426

  • 21. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
    Wu X, Lin L, Wu H.
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
    [Abstract] [Full Text] [Related]

  • 22. Esculin Inhibits the Inflammation of LPS-Induced Acute Lung Injury in Mice Via Regulation of TLR/NF-κB Pathways.
    Tianzhu Z, Shumin W.
    Inflammation; 2015 Aug; 38(4):1529-36. PubMed ID: 25676436
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fibroblast Growth Factor 21 dependent TLR4/MYD88/NF-κB signaling activation is involved in lipopolysaccharide-induced acute lung injury.
    Gao J, Liu Q, Li J, Hu C, Zhao W, Ma W, Yao M, Xing L.
    Int Immunopharmacol; 2020 Mar; 80():106219. PubMed ID: 31991373
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway.
    Yao H, Hu C, Yin L, Tao X, Xu L, Qi Y, Han X, Xu Y, Zhao Y, Wang C, Peng J.
    Int Immunopharmacol; 2016 Jul; 36():132-141. PubMed ID: 27135544
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rifampicin ameliorates lipopolysaccharide-induced cognitive and motor impairments via inhibition of the TLR4/MyD88/NF-κB signaling pathway in mice.
    Bi W, Cheng X, Zeng Z, Zhou R, Luo R, Zhang J, Zhu L.
    Neurol Res; 2021 May; 43(5):358-371. PubMed ID: 33749522
    [Abstract] [Full Text] [Related]

  • 34. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J, Huang X, Hu S, He H, Meng Z.
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [Abstract] [Full Text] [Related]

  • 35. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L, Li L, Lu S, Li K, Su Z, Wang Y, Fan X, Li X, Zhao G.
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
    Feng G, Sun B, Liu HX, Liu QH, Zhao L, Wang TL.
    Int Immunopharmacol; 2019 Jul; 72():176-185. PubMed ID: 30986645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.